The website for NABIHEAL, the EU-funded Horizon Europe project developing biomaterials for complex wound healing, is now online. Find out more about the project and what its impact will be, and browse the 14 partners from 7 countries to see how each contributes to the project’s objectives.
The Horizon Europe project NABIHEAL is coordinated by the Center for Biomedical Research Network (CIBER) at the Institute of Materials Science of Barcelona (ICMAB-CSIC) by ICMAB researcher Nora Ventosa.
The project was launched on 11-12 January 2023 in Barcelona with the first meeting of the international consortium, formed by 14 partners from 7 countries, including research centers, universities, and private companies.
NABIHEAL is also on LinkedIn - are you? You can view the project profile and follow the project in LinkedIn to stay up-to-date on the progress and find out at which conferences and events you can meet the project participants.
Read more about the project and the press impacts it received in this previous post in our website.
Complex wounds are a global health problem with significant impact on the health care economy. In developed countries alone, they impact the quality of life of more than 2% of total population. Complex wounds, including chronic wounds or major burns, are highly susceptible to microbial infection and biofilm formation, and difficult to treat. Moreover, silver is a widely used metal in antimicrobial products to treat wound infections. However, silver-based products are expensive, and show several drawbacks due to costs, as well as environmental and safety concerns.
The NABIHEAL project will develop multifunctional biomaterials, from proof-of-concept (TRL 3) to the preclinical regulatory stage (TRL 5), to improve wound management. The resulting biomaterials will enable affordable treatment of wound infections or prevention of complications during all phases of the wound healing process.
In the short and medium term, NABIHEAL will develop at least two innovative multifunctional wound-healing biomaterials, using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a game-changing alternative to silver in wound-healing dressings.
A consortium comprising 5 SMEs and 9 academic institutions, with expertise in wound-healing product development, evaluation and commercialization, nanotechnology, safety, and regulatory affairs, will join forces to address these ambitious objectives.
This project received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101092269.